Zevra Therapeutics, Inc. Short-term Investments
Zevra Therapeutics, Inc. (ZVRA) had Short-term Investments of $5.83 million as of 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:ShortTermInvestments · last filed 2022-11-10
- 2022-09-30: Short-term Investments $5.83M.
- 2022-06-30: Short-term Investments $4.20M.
- 2021-12-31: Short-term Investments $0.00.
| Period end | Short-term Investments |
|---|---|
| 2022-09-30 | $5.83M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $4.20M 10-Q · filed 2022-08-12 |
| 2021-12-31 | $0.00 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |